Warning
Mae'r hysbyseb swydd hon wedi dod i ben ac mae'r ceisiadau wedi cau.
Consultant Clinical Oncologist | The Christie NHS Foundation Trust
| Dyddiad hysbysebu: | 29 Hydref 2025 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £109,725 - £145,478 Per annum pro rata |
| Oriau: | Rhan Amser |
| Dyddiad cau: | 28 Tachwedd 2025 |
| Lleoliad: | Manchester, M20 4BX |
| Cwmni: | The Christie NHS Foundation Trust |
| Math o swydd: | Parhaol |
| Cyfeirnod swydd: | 7582553/413-MD-2025-24655-OO |
Crynodeb
This Job is pending RCR Approval.
An exciting opportunity has arisen to join the Clinical Network Services Division, as a permanent 8PA Clinical Oncology Lung Consultant working among a multi-disciplinary team to offer specialist medical input for patients within the Lung disease group.
The post-holder will work alongside the current Lung Consultant Clinical Oncology Team and it is envisaged that the post holder will have clinical commitments in Lung oncology and be actively involved in this disease group, further developing the group’s interests by participating in clinical and research activity.
The successful candidate will be highly motivated and driven to improve patient care and experience. They will be an excellent oral and written communicator and they will use their well-developed clinical and professional leadership skills to encourage and promote best outcomes for patients, their relatives, and their carers. Excellent interpersonal skills are paramount for this post together with confidence to engage and work with a range of colleagues at all levels and from all professional groups.
The appointee will be expected to develop a significant interest in Lung Oncology delivering radiotherapy including SABR and systemic therapy.
The post holder will be one of 9 Clinical Oncology specialising in lung cancer and will be an active member of the MDT. The Lung Consultant team is supported by 5 ANP’s and 8 CNS’s.
The post holder will be actively involved in delivering all aspects of Radiotherapy including SABR. The post is also likely to deliver systemic therapy for NSCLC. The well supported team structure and ethos facilitates cross-cover of clinical work. Training/mentorship can be provided if required, working along side qualified experienced Nursing, Physics and Radiographic colleagues.
The Christie is one of Europe’s leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country.
We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years.
We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.
It is envisaged that the post holder will have clinical commitments in Lung Oncology, being actively involved in the disease group. The outpatient clinics will be held at the Christie Withington site and Royal Oldham. The appointee will be a member of the NE sector MDT.
The appointee will be expected to develop a significant interest in Lung Oncology delivering radiotherapy including SABR and systemic therapy.
The post holder will be one of 9 Clinical Oncology specialising in lung cancer and will be an active member of the MDT. The Lung Consultant team is supported by 5 ANP’s and 8 CNS’s.
The post holder will be actively involved in delivering all aspects of Radiotherapy including SABR. The post is also likely to deliver systemic therapy for NSCLC. The well supported team structure and ethos facilitates cross-cover of clinical work. Training/mentorship can be provided if required, working along side qualified experienced Nursing, Physics and Radiographic colleagues.
There is currently collaborative working within both the Lung Medical and Clinical Oncology research teams which the successful applicant will be expected to participate in. There are opportunities for involvement in technical radiotherapy including SABR, Protons and MR Linac. The team has a strong commitment to research and trial activity in which the appointee would be expected to be involved. The post holder is expected to take on leadership, training and management roles (for example metastatic cord compression lead).
The post holder is expected to help contribute to the development of a rapid palliative radiotherapy service in conjunction with an advance practitioner. The expectation is the new patient numbers will be up to 28- per year. This is likely to result in very low admission numbers and the post holder will be responsible for their own patients.
The appointee will have office accommodation and access to secretarial support
This advert closes on Thursday 20 Nov 2025
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.